General Information

The preservative-free formulation of the Fluzone Influenza Virus Vaccine was approved in September 2002 to immunize high-risk and normal infants, aged six months to 35 months.

Fluzone is also available in its non-preservative-free formulation for pediatric and adult patients.

Additional Information

For further information about Fluzone, visit the Aventis Pasteur vaccine product web site at www.vaccineshoppe.com.